Symbol="CLDX"
AssetType="Common Stock"
Name="Celldex Therapeutics Inc"
Description="Celldex Therapeutics, Inc., a biopharmaceutical company, is dedicated to the development of therapeutic monoclonal and bispecific antibodies for the treatment of various diseases. The company is headquartered in Hampton, New Jersey."
CIK="744218"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES"
Address="53 FRONTAGE ROAD, SUITE 220, HAMPTON, NJ, US"
FiscalYearEnd="December"
LatestQuarter="2023-06-30"
MarketCapitalization="1348823000"
EBITDA="-118431000"
PERatio="None"
PEGRatio="0"
BookValue="5.87"
DividendPerShare="0"
DividendYield="0"
EPS="-2.37"
RevenuePerShareTTM="0.069"
ProfitMargin="0"
OperatingMarginTTM="-37.26"
ReturnOnAssetsTTM="-0.216"
ReturnOnEquityTTM="-0.352"
RevenueTTM="3254000"
GrossProfitTTM="-79901000"
DilutedEPSTTM="-2.37"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="0.644"
AnalystTargetPrice="59.57"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="1935.11"
PriceToBookRatio="5.07"
EVToRevenue="1326.45"
EVToEBITDA="-16.28"
Beta="2.1"
num_52WeekHigh="48.4"
num_52WeekLow="27.01"
num_50DayMovingAverage="34.15"
num_200DayMovingAverage="37.5"
SharesOutstanding="47260800"
DividendDate="2019-02-11"
ExDividendDate="None"
symbol="CLDX"
open="28.82"
high="28.85"
low="28.29"
price="28.54"
volume="780032.00"
latest_trading_day="2023-08-25"
previous_close="28.69"
change="-0.15"
change_percent="-0.5228%"
aroon_positive_momentum_days="0"
aroon_negative_momentum_days="64"
trend_strength="Absent or Weak Trend"
buying_signal="Weak Sell Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="36"
Volume_recent_avg="529185"
Change_recent_avg="-0.02"
Delta_recent_avg="1.45"
Variance_recent_avg="0.73"
Change_ratio_recent_avg="-0.08"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="negative"
Aroon_change="FALSE"
Aroon_momentum_positive="36"
Aroon_momentum_negative="64"
image_negative_thumbnail_id_1="1121"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0154.jpeg"
image_negative_thumbnail_id_2="1157"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0191.jpeg"
image_neutral_thumbnail_id_1="538"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0061.jpeg"
image_neutral_thumbnail_id_2="575"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0024.jpeg"
image_positive_thumbnail_id_1="682"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0026.jpeg"
image_positive_thumbnail_id_2="983"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0145.jpeg"
image_professor_thumbnail_id_1="1202"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0036.jpeg"
image_professor_thumbnail_id_2="1189"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0023.jpeg"
